AlphaCentric Advisors LLC

SEC CIK: 0001913464
Latest filing: Jul 24, 2026

SEC filings (opens in a new tab)

CERE holding history

Cerevel Therapeutics Holdings, Inc. in every 13F filed by AlphaCentric Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CERE overview All 13F holders of CERE Full Q2 2026 holdings

Shares (Q3 2024): 0; Sold out in Q3 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q4 2023

Holdings of CERE by AlphaCentric Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2024	0	$0	0.0%	−42,500−100.0%	Sold out	Holders
Q2 2024	42,500	$1.74M	1.3%	00.0%	Unchanged	Holders
Q1 2024	42,500	$1.80M	1.1%	+17,500+70.0%	Added	Holders
Q4 2023	25,000	$1.06M	0.7%	+25,000	New	Holders